Frühes NSCLC: Die präoperative Milzgröße ist ein Prognosefaktor für das Überleben

T. Lesser
{"title":"Frühes NSCLC: Die präoperative Milzgröße ist ein Prognosefaktor für das Überleben","authors":"T. Lesser","doi":"10.1159/000536235","DOIUrl":null,"url":null,"abstract":"Background: The correlation between the preoperative splenic area measured on CT scans and the overall survival (OS) of early-stage non-small cell lung cancer (NSCLC) patients remains unclear. Methods: A retrospective discovery cohort and validation cohort consisting of consecutive NSCLC patients who underwent resection and preoperative CT scans were created. The patients were divided into two groups based on the measurement of their preoperative splenic area: normal and abnormal. The Cox proportional hazard model was used to analyse the correlation between splenic area and OS. Results: The discovery and validation cohorts included 2532 patients (1374 (54.27%) males; median (IQR) age 59 (52–66) years) and 608 patients (403 (66.28%) males; age 69 (62–76) years), respectively. Patients with a normal splenic area had a 6% higher 5-year OS (n = 727 (80%)) than patients with an abnormal splenic area (n = 1805 (74%)) (p = 0.007) in the discovery cohort. A similar result was obtained in the validation cohort. In the univariable analysis, the OS hazard ratios (HRs) for the patients with abnormal splenic areas were 1.32 (95% confidence interval (CI): 1.08, 1.61) in the discovery cohort and 1.59 (95% CI: 1.01, 2.50) in the validation cohort. Multivariable analysis demonstrated that abnormal splenic area was independent of shorter OS in the discovery (HR: 1.32, 95% CI: 1.08, 1.63) and validation cohorts (HR: 1.84, 95% CI: 1.12, 3.02). Conclusion: Preoperative CT measurements of the splenic area serve as a prognostic indicator for early-stage NSCLC patients, offering a novel metric with potential implications for personalized therapeutic strategies in top-tier oncology research.","PeriodicalId":509407,"journal":{"name":"Kompass Pneumologie","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Kompass Pneumologie","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1159/000536235","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The correlation between the preoperative splenic area measured on CT scans and the overall survival (OS) of early-stage non-small cell lung cancer (NSCLC) patients remains unclear. Methods: A retrospective discovery cohort and validation cohort consisting of consecutive NSCLC patients who underwent resection and preoperative CT scans were created. The patients were divided into two groups based on the measurement of their preoperative splenic area: normal and abnormal. The Cox proportional hazard model was used to analyse the correlation between splenic area and OS. Results: The discovery and validation cohorts included 2532 patients (1374 (54.27%) males; median (IQR) age 59 (52–66) years) and 608 patients (403 (66.28%) males; age 69 (62–76) years), respectively. Patients with a normal splenic area had a 6% higher 5-year OS (n = 727 (80%)) than patients with an abnormal splenic area (n = 1805 (74%)) (p = 0.007) in the discovery cohort. A similar result was obtained in the validation cohort. In the univariable analysis, the OS hazard ratios (HRs) for the patients with abnormal splenic areas were 1.32 (95% confidence interval (CI): 1.08, 1.61) in the discovery cohort and 1.59 (95% CI: 1.01, 2.50) in the validation cohort. Multivariable analysis demonstrated that abnormal splenic area was independent of shorter OS in the discovery (HR: 1.32, 95% CI: 1.08, 1.63) and validation cohorts (HR: 1.84, 95% CI: 1.12, 3.02). Conclusion: Preoperative CT measurements of the splenic area serve as a prognostic indicator for early-stage NSCLC patients, offering a novel metric with potential implications for personalized therapeutic strategies in top-tier oncology research.
早期 NSCLC:术前脾脏大小是生存率的预后因素
背景:CT 扫描所测得的术前脾脏面积与早期非小细胞肺癌(NSCLC)患者总生存期(OS)之间的相关性仍不清楚。研究方法建立一个回顾性发现队列和验证队列,队列由接受切除术和术前 CT 扫描的连续 NSCLC 患者组成。根据术前脾脏面积的测量结果将患者分为两组:正常组和异常组。采用 Cox 比例危险模型分析脾脏面积与 OS 之间的相关性。结果显示发现组和验证组分别包括 2532 名患者(男性 1374 人(54.27%);中位数(IQR)年龄 59(52-66)岁)和 608 名患者(男性 403 人(66.28%);年龄 69(62-76)岁)。在发现队列中,脾脏面积正常患者的 5 年 OS(n = 727 (80%))比脾脏面积异常患者(n = 1805 (74%))高 6%(p = 0.007)。在验证队列中也得到了类似的结果。在单变量分析中,发现队列中脾脏面积异常患者的 OS 危险比 (HR) 为 1.32(95% 置信区间 (CI):1.08, 1.61),验证队列中为 1.59(95% CI:1.01, 2.50)。多变量分析表明,在发现队列(HR:1.32,95% CI:1.08,1.63)和验证队列(HR:1.84,95% CI:1.12,3.02)中,异常脾脏面积与较短的OS无关。结论术前CT测量脾脏面积可作为早期NSCLC患者的预后指标,为顶级肿瘤学研究中的个性化治疗策略提供了一种新的衡量标准,具有潜在的意义。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信